NeuroOne Medical Technologies Cash Flow Statement 2020-2024 | NMTC

Fifteen years of historical annual cash flow statements for NeuroOne Medical Technologies (NMTC).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-11.86$-10.00$-9.95$-13.64
$0.15$0.11$0.08$0.05
$1.25$1.16$1.78$10.60
$1.40$1.27$1.86$10.64
$0.03$0.02$-0.05$0
$-1.02$-0.61$-0.10$0
$-0.25$0.52$-0.35$-0.27
$-1.19$1.29$-0.02$-0.16
$-2.43$1.21$-0.51$-0.43
$-12.89$-7.52$-8.60$-3.43
$-0.38$-0.28$-0.07$-0.12
$0$0$0$0
$0$0$0$0
$3.03$-2.97$0$0
$0$0$0$0
$3.03$-2.97$0$0
$0$0$0$0
$2.65$-3.24$-0.07$-0.12
$0$0$0$0
$0$0$0$8.36
$0$0$0$8.36
$7.40$12.02$11.59$0.01
$7.40$12.02$11.59$0.01
$0$0$0$0
$0$0$-0.05$-1.04
$7.40$12.02$11.53$7.32
$-2.84$1.26$2.86$3.78
$1.11$0.95$1.79$1.84
$0$0$0$0